Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy

BACKGROUND: In patients receiving immune checkpoint inhibitor (ICI) therapy, acute kidney injury (AKI) is common, and can occur either from kidney injury unrelated to ICI use or from immune activation resulting in acute interstitial nephritis (AIN). In this study, we test the hypothesis that occurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Megan L, Yamamoto, Yu, Perazella, Mark A, Dizman, Nazli, Shirali, Anushree C, Hafez, Navid, Weinstein, Jason, Simonov, Michael, Testani, Jeffrey M, Kluger, Harriet M, Cantley, Lloyd G, Parikh, Chirag R, Wilson, F Perry, Moledina, Dennis G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968986/
https://www.ncbi.nlm.nih.gov/pubmed/35354588
http://dx.doi.org/10.1136/jitc-2021-004421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968986/
https://www.ncbi.nlm.nih.gov/pubmed/35354588
http://dx.doi.org/10.1136/jitc-2021-004421

Ejemplares similares